Richard A Graham Theravance Biopharma, Inc. (TBPH) insider trading activity

Richard A Graham is SVP, RESEARCH & DEVELOPMENT of Theravance Biopharma, Inc.. Currently has a direct ownership of 314,915 shares of TBPH, which is worth approximately $2.59 Million. The most recent transaction as insider was on Feb 20, 2024, when has been sold 19,294 shares (Ordinary Shares) at a price of $8.92 per share, resulting in proceeds of $172,102. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 315K

0% 3M change

9.85% 12M change

Total Value Held $2.59 Million

RICHARD A GRAHAM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2024	SELL Payment of exercise price or tax liability	$172,102 $8.92 p/Share	19,294 Reduced 5.77%	314,915 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$130,973 $10.37 p/Share	12,630 Reduced 3.64%	334,209 Ordinary Shares
Nov 14 2023	SELL Open market or private sale	$25,366 $10.22 p/Share	2,482 Reduced 0.71%	346,839 Ordinary Shares
Oct 30 2023	BUY Grant, award, or other acquisition	-	15,000 Added 4.12%	349,321 Ordinary Shares
Oct 16 2023	SELL Open market or private sale	$22,412 $9.03 p/Share	2,482 Reduced 0.74%	334,321 Ordinary Shares
Sep 14 2023	SELL Open market or private sale	$24,546 $9.89 p/Share	2,482 Reduced 0.73%	336,803 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$101,471 $9.7 p/Share	10,461 Reduced 2.99%	339,285 Ordinary Shares
Aug 11 2023	SELL Open market or private sale	$23,196 $9.99 p/Share	2,322 Reduced 0.66%	349,746 Ordinary Shares
Jul 14 2023	SELL Open market or private sale	$22,848 $9.84 p/Share	2,322 Reduced 0.66%	352,068 Ordinary Shares
Jun 14 2023	SELL Open market or private sale	$24,822 $10.69 p/Share	2,322 Reduced 0.65%	354,390 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$117,256 $11.21 p/Share	10,460 Reduced 2.85%	356,712 Ordinary Shares
May 15 2023	SELL Open market or private sale	$26,145 $11.26 p/Share	2,322 Reduced 0.63%	367,172 Ordinary Shares
Apr 14 2023	SELL Open market or private sale	$27,597 $11.88 p/Share	2,323 Reduced 0.62%	369,494 Ordinary Shares
Mar 14 2023	SELL Open market or private sale	$23,973 $10.32 p/Share	2,323 Reduced 0.62%	371,817 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$23,346 $10.05 p/Share	2,323 Reduced 0.62%	374,140 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	75,000 Added 16.61%	376,463 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$125,875 $10.44 p/Share	12,057 Reduced 3.85%	301,463 Ordinary Shares
Dec 01 2022	SELL Open market or private sale	$22,361 $10.73 p/Share	2,084 Reduced 0.66%	313,520 Ordinary Shares
Nov 20 2022	SELL Payment of exercise price or tax liability	$296,747 $10.85 p/Share	27,350 Reduced 7.97%	315,604 Ordinary Shares
Nov 16 2022	SELL Payment of exercise price or tax liability	$31,359 $11.2 p/Share	2,800 Reduced 0.81%	342,954 Ordinary Shares
Aug 19 2022	SELL Payment of exercise price or tax liability	$177,376 $9.34 p/Share	18,991 Reduced 5.21%	345,754 Ordinary Shares
Aug 16 2022	SELL Open market or private sale	$47,637 $9.71 p/Share	4,906 Reduced 1.33%	364,745 Ordinary Shares
Aug 09 2022	SELL Open market or private sale	$132,606 $8.79 p/Share	15,086 Reduced 3.92%	369,651 Ordinary Shares
May 20 2022	SELL Payment of exercise price or tax liability	$34,497 $8.74 p/Share	3,947 Reduced 1.02%	384,737 Ordinary Shares
Feb 18 2022	SELL Payment of exercise price or tax liability	$195,823 $9.61 p/Share	20,377 Reduced 4.98%	388,684 Ordinary Shares

RAG

Richard A Graham

SVP, RESEARCH & DEVELOPMENT

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account